|
KIAA1033 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.921800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.131590E-01 |
| Normal-vs-Stage2 |
1.045560E-01 |
| Normal-vs-Stage3 |
9.574400E-02 |
| Normal-vs-Stage4 |
3.570200E-01 |
| Stage1-vs-Stage2 |
3.803600E-01 |
| Stage1-vs-Stage3 |
4.683800E-01 |
| Stage1-vs-Stage4 |
6.811200E-01 |
| Stage2-vs-Stage3 |
8.321600E-01 |
| Stage2-vs-Stage4 |
8.386000E-01 |
| Stage3-vs-Stage4 |
9.589000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.356100E-02 |
| Normal-vs-AfricanAmerican |
2.139900E-02 |
| Normal-vs-Asian |
4.149800E-01 |
| Caucasian-vs-AfricanAmerican |
3.876000E-01 |
| Caucasian-vs-Asian |
8.593800E-01 |
| AfricanAmerican-vs-Asian |
8.997000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.198340E-02 |
| Normal-vs-Female |
3.579700E-02 |
| Male-vs-Female |
8.082400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.348600E-01 |
| Normal-vs-Extreme_Weight |
7.843600E-01 |
| Normal-vs-Obese |
2.737500E-02 |
| Normal-vs-Extreme_Obese |
7.771600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.508400E-01 |
| Normal_Weight-vs-Obese |
3.698400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.191400E-01 |
| Extreme_Weight-vs-Obese |
5.290400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.519600E-01 |
| Obese-vs-Extreme_Obese |
1.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.982800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.008900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.378800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.675800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.358800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.441520E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.303770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.185700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.782200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.908000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.122300E-03 |
| Normal-VS-Type2 PRCC |
9.948300E-02 |
| Normal-VS-KIRP CIMP |
6.473800E-01 |
| Normal-VS-Unclassified PRCC |
3.392400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.506800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.447800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.670000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.136400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.497200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.764200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.165200E-01 |
| Normal-vs-N1 |
5.086400E-02 |
| Normal-vs-N2 |
1.540350E-01 |
| N0-vs-N1 |
3.579800E-01 |
| N0-vs-N2 |
3.320600E-01 |
| N1-vs-N2 |
1.531550E-01 |
|
|
